K Number
K140005
Device Name
ALMA DIODE TABLETOP LASER
Manufacturer
Date Cleared
2014-07-18

(197 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Intended Use The Alma Diode Tabletop Laser is intended for use in dermatologic and general surgical procedures. Indications for Use The Alma Diode Tabletop Laser includes three possible diode laser modules depending on the customer order. Diode Laser Modules: The indications for use for the 810nm Alma Diode Tabletop Laser include: - The Alma 810nm diode tabletop laser is indicated for endovenous laser surgery for saphenous incompetent veins. The indications for use for the 980 nm Alma Diode Tabletop Laser include: -The Alma 980nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 980nm diode tabletop laser is further indicated for laser assisted lipolysis. The indications for use for the 1470nm Alma Diode Tabletop Laser include: -The Alma 1470nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 1470nm diode tabletop laser is further indicated for laser assisted lipolysis.
Device Description
The Alma Diode Tabletop Laser is comprised of the following major components: - 1. The main console unit - 2. Footswitch. - 3. Accessories
More Information

Not Found

No
The provided 510(k) summary describes a laser device for surgical procedures and does not mention any AI or ML components, image processing, or data sets typically associated with AI/ML applications.

Yes
The device is used in surgical procedures and specific medical treatments like endovenous laser surgery and laser-assisted lipolysis, which aim to treat medical conditions.

No

The device is described as a laser intended for dermatologic and general surgical procedures, specifically for endovenous laser surgery, occlusion, and laser-assisted lipolysis. These are therapeutic procedures, not diagnostic ones. Although it cites IEC 60601-2-22, which mentions "diagnostic and therapeutic laser equipment," the intended uses listed for this specific device are all therapeutic.

No

The device description explicitly lists hardware components such as a main console unit, footswitch, and accessories, indicating it is a physical device, not software-only.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use and Indications for Use: The intended use and indications clearly describe the device as a laser used for surgical procedures on the human body (endovenous laser surgery, laser assisted lipolysis). IVDs are used to examine specimens from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
  • Device Description: The description lists components like a main console unit, footswitch, and accessories, which are typical for a surgical laser device, not an IVD.
  • Performance Studies: The performance studies mentioned are related to electrical safety and laser safety standards (IEC 60601 series, IEC 60825-1), which are relevant for medical devices used on patients, not for evaluating the analytical or clinical performance of an IVD.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, or providing diagnostic information based on in vitro testing.

In summary, the Alma Diode Tabletop Laser is a therapeutic medical device used for surgical interventions, not a diagnostic device used for testing samples outside the body.

N/A

Intended Use / Indications for Use

The Alma Diode Tabletop Laser is intended for use in dermatologic and general surgical procedures.

Indications for Use
Diode Laser Modules:
The indications for use for the 810nm Alma Diode Tabletop Laser include:

  • The Alma 810nm diode tabletop laser is indicated for endovenous laser surgery for saphenous incompetent veins.

The indications for use for the 980 nm Alma Diode Tabletop Laser include:
-The Alma 980nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 980nm diode tabletop laser is further indicated for laser assisted lipolysis.

The indications for use for the 1470nm Alma Diode Tabletop Laser include:
-The Alma 1470nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 1470nm diode tabletop laser is further indicated for laser assisted lipolysis.

Product codes

GEX

Device Description

The Alma Diode Tabletop Laser is comprised of the following major components:

    1. The main console unit
    1. Footswitch.
    1. Accessories

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

greater saphenous vein, soft tissue

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K100058

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

JUL 1 8 2014

K140005

Section 8 - 510(k) Summary or 510(k) Statement

l, General Information

Submitter:

Alma Lasers, Ltd, Halamish St. POB 3021 Caesarea Industrial Park, Caesarea, Israel 38900

Contact Person:

Kathy Maynor Consultant 352-586-3113 (cell)

Summary Preparation Date:

Dec 30, 2013

  • II. Names
Device Names:The Alma Diode Tabletop Laser
-----------------------------------------------------

Surgical Powered Light Instrument, Primary Classification Names:

III. Predicate Devices

. Predicate Device ___________________________________________________________________________________________________________________________________________________________ K # ** K100058 Quanta Diode Laser Family

IV. Product Description

The Alma Diode Tabletop Laser is comprised of the following major components:

    1. The main console unit
    1. Footswitch.
    1. Accessories

V. Indications for Use

The Alma diode tabletop laser is intended for use in dermatologic and general surgical procedures.

1

VI. Summary of Technical Characteristics

.

K13K100558
Alma diode tabletop laserQuanta Diode Laser Family
Parameter
Product Code &
Regulation No.GEX
21 CFR 878.4810GEX
21 CFR 878.4810
Laser Wavelength [nm]14701470
Max power15W15W
Light/Laser SourceDiodeDiode
Laser DeliveryOptical FiberOptical Fiber
Operation ModeContinuous wave, single pulse, pulsedContinuous wave, single pulse, pulsed
Pulse Duration10-990ms3ms - 2.5s
Bare fiber size200, 300, 320, 400, 600, 800, 1000200, 300, 320, 400, 600, 800, 1000
User InterfaceLCD touch screenLCD touch screen
Aiming beam635nm650nm
Electrical Requirements100-240. V AC 50-60 Hz, 6.3 A100-240, V AC 50-60 Hz, 6.3 A, single phase,
Indications for UseThe Alma 1470nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 1470nm diode tabletop laser is further indicated for laser assisted lipolysis,The QUANTA Diode Laser System is intended for delivery of laser light to soft tissue in the contact and non contact mode during surgical procedures including via endoscopes. The QUANTA Diode Laser System is generally indicated for use in endovenous occlusion of the greater saphenous vein in Patients with Superficial Vein Reflux. The QUANTA1470 Diode Laser is further indicated for laser assisted lipolysis

.

.

.

Table 1: Salient Characteristics of the 1470nm module and the Predicate Devices

·

:

:

2/5

י

:

2

Table 2: Salient Characteristics of the 980nm module and the Predicate Devices

K13K100558
Alma diode tabletop laserQuanta Diode Laser Family
Parameter
Product
Code &
Regulation
No.GEX
21 CFR 878.4810GEX
21 CFR 878.4810
Laser
Wavelength
[nm]980nm980nm
Max power30W30W
Light/Laser
SourceDiodeDiode
Laser
DeliveryOptical FiberOptical Fiber
Operation
ModeContinuous wave, single
pulse, pulsedContinuous wave, single pulse,
pulsed
Pulse
Duration10-990ms3ms - 2.5s
Bare fiber
size200, 300, 320, 400, 600, 800,
1000200, 300, 320, 400, 600, 800,
1000
User
InterfaceLCD touch screenLCD touch screen
Aiming beam635nm650nm
Electrical
Requirements100-240, V AC 50-60 Hz, 6.3
A,100-240, V AC 50-60 Hz, 6.3 A.
single phase.
Indications
for UseThe Alma 980nm diode
tabletop laser is indicated
for use in endovenous
occlusion of the greater
saphenous vein in patients
with superficial vein
reflux. The Alma 980nm
diode tabletop laser is
further indicated for laser
assisted lipolysis,The QUANTA Diode Laser
System is intended for delivery of
laser light to soft tissue in the
contact and non contact mode
during surgical procedures
including
via endoscopes. The QUANTA
Diode Laser System is generally
indicated for use in endovenous
occlusion of the greater
saphenous vein in Patients with
Superficial Vein Reflux. The
QUANTA980 Diode
Laser is further indicated for laser
assisted lipolysis. (This is a
subset of the cleared indications
for this product)

·

.

: 3/5

·

3

Table 3: Salient Characteristics of 810nm diode module and the predicate devices

·

વે

K13K100558
Alma diode tabletop laserQuanta Diode Laser Family
Parameter
Product
Code &
Regulation
No.GEX
21 CFR 878.4810GEX
21 CFR 878.4810
Laser
Wavelength
[nm]810nm808nm
Max power30W30W
Light/Laser
SourceDiodeDiode
Laser
DeliveryOptical FiberOptical Fiber
Operation
ModeContinuous wave, single
pulse, pulsedContinuous wave, single pulse,
pulsed
Pulse
Duration10-990ms3ms - 2.5s
Bare fiber
size200, 300, 320, 400, 600, 800,
1000200, 300, 320, 400, 600, 800,
1000
User
InterfaceLCD touch screenLCD touch screen
Aiming beam635nm650nm
Electrical
Requirements100-240, V AC 50-60 Hz, 6.3
A.100-240, V AC 50-60 Hz, 6.3 A,
single phase,
Indications
for UseThe Alma 810nm diode
tabletop laser is indicated
for endoluminal or
endovenous laser surgery
for saphenous incompetent
veins.The QUANTA Diode Laser
System is intended for delivery of
laser light to soft tissue in the
contact and non contact mode
during surgical procedures
including
via endoscopes. The QUANTA
808 Diode Laser System is
generally indicated for
endoluminal or endovenous laser
surgery for saphenous
incompetent veins. (This is a
subset of the cleared indications
for this product).

·

.

4 / 5

4

VII. Safety and Effectiveness Information

The review of the indications for use and technical characteristics provided demonstrates that the Alma diode tabletop laser is substantially equivalent to the predicate devices.

The Diode Tabletop Laser was tested by a certified laboratory according to:

IEC 60601-1: 1988+A1:1991+A2:1995: Medical Electrical Equipment Part 1: General Requirements for basic safety and essential performance

IEC 60601-1-2: Medical electrical equipment: Part 1-2: General requirements for safety-Collateral Standard: Electromagnetic compatibility - Requirements and tests (2001 + A1(4))

IEC 60601-2-22:1995 Medical electrical equipment- Part 2-22: Particular requirements for the safety of diagnostic and therapeutic laser equipment 1995.

IEC 60825-1:2007 (2nd edition) Safety of Laser Products-Part 1: Equipment Classification and Requirements

Conclusion VIII.

The Alma diode tabletop laser was found to be substantially equivalent to the predicate devices.

The Alma diode tabletop laser shares the same or similar indications for use, similar design features, and functional features with, and thus is substantially equivalent to the predicate devices.

5

Image /page/5/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its wings or feathers. The eagle is positioned to the right of a circular border containing the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 18, 2014

Alma Lasers Ltd. % Ms. Kathy Maynor Regulatory Consultant for Alma LTD 26 Rebecca Court Homosassa. Florida 34446

Re: K140005

Trade/Device Name: The Alma Diode Tabletop Laser Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: GEX Dated: April 29, 2014 Received: June 20, 2014

Dear Ms. Maynor:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act that I DA has intatutes and regulations administered by other Federal agencies. You must or any reath all the Act s requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

6

Page 2 - Ms. Kathy Maynor

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

David Krause -S

  • Binita S. Ashar, M.D., M.B.A., F.A.C.S. for Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
    Enclosure

7

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510(k) Number (if known)K140005
-----------------------------------

Device Name The Alma Diode Tabletop Laser

Indications for Use (Describe) Intended Use The Alma Diode Tabletop Laser is intended for use in dermatologic and general surgical procedures.

Indications for Use The Alma Diode Tabletop Laser includes three possible diode laser modules depending on the customer order.

Diode Laser Modules:

The indications for use for the 810nm Alma Diode Tabletop Laser include:

  • The Alma 810nm diode tabletop laser is indicated for endovenous laser surgery for saphenous incompetent veins.

The indications for use for the 980 nm Alma Diode Tabletop Laser include:

-The Alma 980nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 980nm diode tabletop laser is further indicated for laser assisted lipolysis.

The indications for use for the 1470nm Alma Diode Tabletop Laser include:

-The Alma 1470nm diode tabletop laser is indicated for use in endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux. The Alma 1470nm diode tabletop laser is further indicated for laser assisted lipolysis.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

Neil R Ogden -S 2014.07.17 16:13:51 -04′00″